Literature DB >> 8091506

Gene therapy for metabolic disorders.

M A Kay1, S L Woo.   

Abstract

Most diseases caused by genetic deficiencies could, in theory, be treated by the introduction and expression of a normal gene into an appropriate target tissue. It seems likely that gene therapy strategies for most metabolic disorders will not require strict gene regulation, as a fraction of the normal levels of gene activity could result in amelioration or significant improvement in the clinical outcome. Gene therapy is making rapid progress towards the goal of treating various disorders: here, we summarize the state of gene therapy for metabolic disorders.

Entities:  

Mesh:

Year:  1994        PMID: 8091506     DOI: 10.1016/0168-9525(94)90173-2

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  18 in total

1.  Efficient c-kit receptor-targeted gene transfer to primary human CD34-selected hematopoietic stem cells.

Authors:  Q Zhong; P Oliver; W Huang; D Good; V La Russa; Z Zhang; J R Cork; R W Veith; C Theodossiou; J K Kolls; P Schwarzenberger
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 2.  Principles of therapeutic liver repopulation.

Authors:  Markus Grompe
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

3.  Receptor-targeted recombinant adenovirus conglomerates: a novel molecular conjugate vector with improved expression characteristics.

Authors:  P Schwarzenberger; J D Hunt; E Robert; C Theodossiou; J K Kolls
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 4.  Liver repopulation for the treatment of metabolic diseases.

Authors:  M Grompe
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

5.  Adenovirus-mediated expression of ribozymes in mice.

Authors:  A Lieber; M A Kay
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

6.  Correction of obesity and diabetes in genetically obese mice by leptin gene therapy.

Authors:  P Muzzin; R C Eisensmith; K C Copeland; S L Woo
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

7.  Development of a high-performance liquid chromatographic assay for G418 sulfate (Geneticin).

Authors:  C Bethune; T Bui; M L Liu; M A Kay; R J Ho
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

8.  Aging accentuates and bone marrow transplantation ameliorates metabolic defects in Fabry disease mice.

Authors:  T Ohshima; R Schiffmann; G J Murray; J Kopp; J M Quirk; S Stahl; C C Chan; P Zerfas; J H Tao-Cheng; J M Ward; R O Brady; A B Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

9.  Efficient gene transfer into human hepatocytes by baculovirus vectors.

Authors:  C Hofmann; V Sandig; G Jennings; M Rudolph; P Schlag; M Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

10.  Membrane-bound alkaline phosphatase gene induces antitumor effect by G2/M arrest in etoposide phosphate-treated cancer cells.

Authors:  Kye Young Kim; Young Joo Cho; Geoung A Jeon; Pan Dong Ryu; Jin Nam Myeong
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.